Gregory DiFelice, MD

Orthopaedic Surgeon at The Hospital for Special Surgery

Articles by Gregory DiFelice, MD

BEAR Implant's Updated FDA Label Reflects Reduced Osteoarthritis Risk, With Gregory DiFelice, MD

April 8th 2026

The FDA's 510(k) clearance for updated BEAR Implant labeling marks the first time a sports medicine product has carried a label claim tied to reduced post-traumatic osteoarthritis risk.

Gregory DiFelice, MD

Articles by Gregory DiFelice, MD

BEAR Implant's Updated FDA Label Reflects Reduced Osteoarthritis Risk, With Gregory DiFelice, MD

Latest Updated Articles

Trending on Rheumatology Live

Joint Ventures Recaps Influential EULAR Studies in SLE, RA, and More

Risankizumab’s Durable Efficacy, Safety in PsA, With Frank Behrens, MD